Your browser doesn't support javascript.
loading
Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians.
Li, Jing; Yang, Jing; Kong, Lingfei; Huang, Yijiang; Chen, Ping; Yan, Xixin; Liu, Xiaoxia; Zho, Xiangdongu; Liu, Jinming; Zhu, Xiaoli; Humphries, Michael; Wang, Linda; Pethe, Abhijit; Wang, Xinting; Kottakis, Ioannis; Fogel, Robert; Zhong, Nanshan.
Afiliação
  • Li J; State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
  • Yang J; Novartis China Global Drug Development, China.
  • Kong L; The First Affiliated Hospital, China Medical University, Shenyang, China.
  • Huang Y; Affiliated Hospital to Hainan Medical University, Haikou, China.
  • Chen P; General Military Hospital, Shenyang, China.
  • Yan X; Second Affiliated Hospital of Hebei Medical University, Hebei Sheng, China.
  • Liu X; Beijing Friendship Hospital of Capital Medical University, Beijing Shi, China.
  • Zho X; Xinan Hospital, Third Military Medical University, Chongqing, China.
  • Liu J; Shanghai Pulmonary Hospital of Tongji University, Shanghai, China.
  • Zhu X; Zhongda Hospital of Southeast University, Nanjing China.
  • Humphries M; Novartis China Global Drug Development, China.
  • Wang L; Biostatistics & Pharmacometrics, NIBR, China.
  • Pethe A; BBiostatistics & Pharmacometrics, Novartis Pharmaceuticals, USA.
  • Wang X; Biostatistics & Pharmacometrics, Novartis Pharmaceuticals, USA.
  • Kottakis I; Global Medical Affairs Novartis Pharma AG, Basel, Switzerland.
  • Fogel R; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Zhong N; State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Asian Pac J Allergy Immunol ; 40(3): 223-231, 2022 Sep.
Article em En | MEDLINE | ID: mdl-32247304
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article